Abstract: Obstructive jaundice is a common clinical symptom generally caused by bile duct stones, inflammatory hyperplasia, and tumors. It is characterized by hyperbilirubinemia and may trigger a variety of complications such as hypotension, kidney injury, endotoxemia, multiple organ dysfunction syndrome, and even death (Pavlidis and Pavlidis, 2018; Liu et al., 2021). Relieving bile duct obstruction and providing adequate drainage have been considered as the most effective therapies for obstructive jaundice. However, it has not yet been established whether it is beneficial to treat affected patients by pre-operative biliary drainage (Blacker et al., 2021). Moreover, the pathophysiological changes or mechanisms associated with the reversal of organ function following the relief of bile-duct obstruction are unclear (Huang et al., 2004). Therefore, it is necessary to establish an experimental model of reversible obstructive jaundice to simulate biliary drainage in clinical practice.

一种新型改良式可逆性梗阻性黄疸大鼠模型的建立

[1]AronsonDC, ChamuleauRAFM, FrederiksWM, et al., 1993. Reversibility of cholestatic changes following experimental common bile duct obstruction: fact or fantasy? J Hepatol, 18(1):85-95.

[2]BlackerS, LahiriRP, PhillipsM, et al., 2021. Which patients benefit from preoperative biliary drainage in resectable pancreatic cancer? Expert Rev Gastroenterol Hepatol, 15(8):855-863.

[3]DuYH, ChenH, XuanZF, et al., 2016. Bile deficiency induces changes in intestinal glucose absorption in mice. Surgery, 160(6):1496-1507.

[4]FrissenM, LiaoLJ, SchneiderKM, et al., 2021. Bidirectional role of NLRP3 during acute and chronic cholestatic liver injury. Hepatology, 73(5):1836-1854.

[5]HirataniS, MoriR, OtaY, et al., 2019. A simple and easily reproducible model of reversible obstructive jaundice in rats. In Vivo, 33(3):699-706.

[6]HuangLT, HsiehCS, ChouMH, et al., 2004. Obstructive jaundice in rats: cause of spatial memory deficits with recovery after biliary decompression. World J Surg, 28(3):283-287.

[7]HuangX, LiCH, ZhangAQ, et al., 2017. A simple rat model of in situ reversible obstructive jaundice in situ reversible obstructive jaundice model. Ann Surg Treat Res, 92(6):389-395.

[8]JiCG, XieXL, YinJ, et al., 2017. Bile acid receptor TGR5 overexpression is associated with decreased intestinal mucosal injury and epithelial cell proliferation in obstructive jaundice. Transl Res, 182:88-102.

[9]KahramansoyN, ErkolH, YilmazEE, et al., 2012. A new model of reversible obstructive jaundice using rapidly absorbable suture materials. Clin Invest Med, 35(6):E351-E357.

[10]LiW, ChungSCS, 2001. An improved rat model of obstructive jaundice and its reversal by internal and external drainage. J Surg Res, 101(1):4-15.

[11]LiuJY, QuJL, ChenHY, et al., 2021. The pathogenesis of renal injury in obstructive jaundice: a review of underlying mechanisms, inducible agents and therapeutic strategies. Pharmacol Res, 163:105311.

[12]LyuSC, WangJ, XuWL, et al., 2021. Therapeutic effect of combining anisodamine with neostigmine on local scar formation following Roux-en-Y choledochojejunostomy in a novel rat model. Front Pharmacol, 12:700050.

[13]OruçMT, ÖzmenMM, HanU, 2009. A new technique for inducing and releasing obstructive jaundice in rats. Eur Surg Res, 43(4):354-359.

[14]PavlidisET, PavlidisTE, 2018. Pathophysiological consequences of obstructive jaundice and perioperative management. Hepatobiliary Pancreat Dis Int, 17(1):17-21.

[15]WuLL, LiW, WangZK, et al., 2013. Bile acid-induced expression of farnesoid X receptor as the basis for superiority of internal biliary drainage in experimental biliary obstruction. Scand J Gastroenterol, 48(4):496-503.